Profitelligence Profitelligence · Filing Ledger Open TEM research →

Form 8-K · Current Report · Filed 2026-05-05

Tempus AI Reports 36.1% Revenue Growth and Raises 2026 Guidance

Tempus AI, Inc. reported a 36.1% year-over-year increase in revenue to $348.1 million for the quarter ended March 31, 2026. Diagnostics revenue grew by 34.7% to $261.1 million, driven by Oncology volume growth of 28%, while Data and Applications revenue increased by 40.5% to $87.0 million. The company raised its full-year 2026 revenue guidance to $1.59 to $1.60 billion and expects full-year 2026 Adjusted EBITDA of approximately $65 million. Tempus also announced strategic collaborations with Merck, Gilead, Northwestern Medicine, NYU Langone Health, and Blood Cancer United to advance precision medicine and patient care.

Filer
Tempus AI Inc. TEM · NASDAQ
Filed
Accession
0001193125-26-206317
CIK
0001717115
Signal
High impactHealthcare

Items reported

Item events

Reported Item

Earnings Beat General Statement Strategic Partnership Raised Guidance

Market reaction

Close before filing

$55.81

Next session

-4.1%

Since filing

-21.4%

Latest close

$43.87

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from TEM reporting the same item, with the next session's move:

Insider tape

Within 45 days of this filing, TEM insiders reported 26 Form 4 transactions — net selling of $10.5M.

Full TEM insider history →

About Tempus AI Inc.

Tempus AI Inc. is a pioneering technology company specializing in the development and application of artificial intelligence solutions across various industries. Its primary function is to harness AI-driven insights to enhance operational efficiency and decision-making processes for enterprises. Tempus AI Inc. is at the forefront of integrating machine learning into sectors such as healthcare, finance, and logistics, where predictive data analytics can provide substantial competitive advantages. The company delivers bespoke AI platforms that enable organizations to streamline complex data sets into actionable intelligence. Its expertise extends to natural language processing and computer vision, offering comprehensive AI tools that drive innovation and efficiency. As a significant player in the tech market, Tempus AI Inc. contributes to setting industry standards for AI deployment, impacting how businesses leverage intelligent technology to improve outcomes and strategic planning. Founded with a mission to propel the development of intelligent systems, Tempus AI Inc. remains a vital contributor to the digital transformation of multiple industries, facilitating the transition towards a more data-driven future.

Exchange NASDAQ Industry Health Information Services Company website ↗

Never miss another TEM filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts